Novartis Ag (NVSEF) Divestments (2013 - 2026)

Novartis Ag has disclosed Divestments across 14 years of filings, most recently posting -$2.0 million for Q1 2026.

• Divestments for Q1 2026 came in at -$2.0 million, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$79.0 million (up 86.16% YoY), and the FY2025 annual result was -$88.0 million, down 182.24% from the prior year.
• Divestments came in at -$2.0 million for Q1 2026 at Novartis Ag, up from -$9.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $164.0 million in Q4 2024 to a low of -$738.0 million in Q4 2023.
• The 5-year median for Divestments is -$74.0 million (2023), against an average of -$107.5 million.
• Across the five-year window, Divestments slumped 2366.67% in 2022 and soared 122.22% in 2024, its largest moves.
• Novartis Ag's Divestments stood at -$148.0 million in 2022, then slumped by 398.65% to -$738.0 million in 2023, then jumped by 122.22% to $164.0 million in 2024, then slumped by 105.49% to -$9.0 million in 2025, then surged by 77.78% to -$2.0 million in 2026.
• The last three Divestments figures came in at -$2.0 million (Q1 2026), -$9.0 million (Q4 2025), and -$64.0 million (Q3 2025), per Business Quant data.